Yves Ribeill

Vorstandsvorsitzender bei

Ribogenics, Inc.

66 Jahre

46 Beziehungen

Health Technology

Consumer Services

Commercial Services

Profil

Yves Joseph Ribeill is the founder of SCYNEXIS, Inc., founded in 1999, where the title held was Director from 2015 to 2016.
Current jobs include Chief Executive Officer at Enodia Therapeutics, President & Chief Executive Officer at Ribogenics, Inc., President & Chief Executive Officer at COREzonada, Inc. since 2017, and Director at Ogeda SA. Former jobs include Executive Chairman at Calyxt, Inc. in 2021, Director at Synergia Medical SA, Principal at Rhone-Poulenc Rorer, Inc., and Principal at Aventis Pharma SA in 2000.
Education includes a doctorate from Université de Montpellier.

Aktive Positionen von Yves Ribeill

Unternehmen	Position	Beginn
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Direktor/Vorstandsmitglied	28.08.2009
COREzonada, Inc. COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering	Vorstandsvorsitzender	01.08.2017
Ribogenics, Inc. Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Vorstandsvorsitzender	-

Alle aktiven Positionen von Yves Ribeill

Ehemalige bekannte Positionen von Yves Ribeill

Unternehmen	Position	Ende
SCYNEXIS, INC.	Gründer	16.03.2016
Aventis Pharma SARL Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Corporate Officer/Principal	01.01.2000
Synergia Medical SA Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices	Direktor/Vorstandsmitglied	-
Calyxt, Inc. Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells	Vorstandsvorsitzender	01.10.2018
Rhone-Poulenc Rorer, Inc. Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Yves Ribeill im Detail an

Ausbildung von Yves Ribeill

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Yves Ribeill im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	9
Rhone-Poulenc Rorer, Inc. Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals	Health Technology
SCYNEXIS, Inc. SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections	Health Technology
Aventis Pharma SARL Aventis Pharma SARL Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Université de Montpellier Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ogeda SA Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs	Health Technology
Calyxt, Inc. Calyxt, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as clinical-stage biotechnology company, engages in development and commercialization of products derived from plant cells	Commercial Services
Synergia Medical SA Synergia Medical SA Packaged SoftwareTechnology Services Develops optoelectronics for neurostimulation medical devices	Technology Services
Ribogenics, Inc. Ribogenics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company	Health Technology
COREzonada, Inc. COREzonada, Inc. BiotechnologyHealth Technology Operates as a biotechnology company working on microbiome re-engineering	Health Technology